Triton Pacific Capital Partners announced the official opening of its Capital Markets office in Laguna Niguel, CA, effective March 1, 2016. Our Investor Relations and Operations office located in Richmond, VA, initially opened in July of 2012, has recently moved offices as of December 2015.
“We are excited to expand Triton Pacific’s footprint into both the Orange County, CA and Richmond, VA markets. These additional offices enable Triton Pacific to strengthen our efforts in Capital Markets, Operations and Investor Relations.” said Brian D. Buehler, Partner of Triton Pacific Capital Partners. “This expansion demonstrates Triton Pacific’s commitment to the Broker Dealer and RIA channels, as well as our Investors.”
The Laguna Niguel, CA office will facilitate the sales and marketing efforts for the firm’s alternative investment programs while the Richmond, VA location will provide the firm’s Operations, Investor Relations and back office support. “As we grow the organization, it’s important to provide the appropriate resources to the firm’s overall strategies and objectives; these offices will do just that,” said Michael Carroll, CFO.
About Triton Pacific Triton Pacific Capital Partners is a private equity firm founded in 2001 that invests in both debt and equity securities of privately held American businesses. Triton Pacific currently manages four private equity funds and is the sponsor of Triton Pacific Investment Corporation, a $300 million public non-traded fund structured as a non-traded business development company, externally managed by Triton Pacific Adviser LLC. Triton Pacific Investment Corporation’s advisor and sub-advisor manage more than $4.3B billion of debt and private equity investments.
www.tritonpacific.com | email@example.com | Fax: 844.943.4995
The Blue Vault Summit could not have been more perfectly timed. This gathering of the Broker Dealer and Sponsor communities provided insightful and open discussion from several vantage points. These conversations are paramount, especially in a time of significant regulatory change.